Life Biosciences

“Sinclair-adjacent partial reprogramming and chaperone programs under one roof.”

Life Bio runs multiple aging bets (including OSK-style eye programs). A platform company for hallmarks, with clinical ambitions.

A flagship therapeutics house on the map.

Series A. Filed from the Top Tier Impact landscape.

Several shots, one house.

Also in this file